Showcases Stock ranks

Bristol-Myers Squibb Company (BMY)
50.13 -1.17 (-2.28%) 02-21 16:00
Open: 51.08 Pre. Close: 51.3
High: 52.8 Low: 50.09
Volume: 25,946,991 Market Cap: 81835M
Share on Facebook   Tweet this page   Tweet this page
Price Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 52.848 - 53.279 53.279 - 53.568
Low: 49.31 - 49.773 49.773 - 50.083
Close: 49.55 - 50.26 50.26 - 50.737
Stock Technical Analysis
Target: Six months: 59.47
One year: 61.66
Support: Support1: 47.88
Support2: 39.84
Resistance: Resistance1: 50.91
Resistance2: 52.79
Pivot: 50.52
Moving Averages: MA(5): 51.06
MA(20): 50.06
MA(100): 52.40
MA(250): 55.83
MACD: MACD(12,26): 0.34
Signal(12,26,9): 0.23
%K %D: %K(14,3): 67.53
%D(3): 80.75
RSI: RSI(14): 49.44
52-Week: High: 68.88
Low: 44.3
Change(%): -23.9
Average Vol(K): 3-Month: 1498349
10-Days: 1450192
Price, MAs and Bollinger Bands
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.

BMY has closed above bottom band by 36.1%. Bollinger Bands are 55.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to BMY's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
According To Sources Bristol-Myers/Celgene: 6 Factors Driving The Deal Spread (Podcast)

U.S. healthcare spending to rise 5.5% per annum over next decade

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1632.46
Shares Float (M) 1626.36
% Held by Insiders
% Held by Institutions 105.60
Shares Short (K) 57527
Shares Short Prior Month (K)
Stock Financials
EPS 3.980
EPS Est. Current Year 3.000
EPS Est. Next Year 3.230
EPS Est. Next Quarter 0.790
Forward EPS 3.720
Book Value (p.s.) 5.950
PEG Ratio 1.25
Profit Margin 23.07
Operating Margin 28.99
Return on Assets (ttm) 22.4
Return on Equity (ttm) 42.2
Qtrly Rev. Growth 9.6
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
P/E 12.60
P/E Growth Ratio -0.02
P/BV 8.43
P/S 5914942464.00
Dividend Yield 0.06
Dividends & Splits
Dividend 3.174
Dividend Pay Date 2019-02-01
Ex-Dividend Date 2019-01-03
Forward Dividend 1.640
Last Split Date
Last Split Ratio -1e+010

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator